New York, NY (November 15, 2012) — About 10 percent of kids born with kidney defects have large alterations in their genomes known to be linked with neurodevelopmental delay and mental illness, a new study by Columbia University Medical Center (CUMC) researchers has shown.
The study was published today in the online edition of the American Journal of Human Genetics.
Congenital defects of the kidney and urinary tract account for nearly 25 percent of all birth defects in the US and are present in about 1 in every 200 births. Eventually, an evaluation for genomic alterations will be part of the standard clinical workup. Patients with congenital kidney disease—who are currently lumped into one category—will be placed in subgroups based on their genetic mutations and receive a more precise diagnosis.
“This changes the way we should handle these kids,” said kidney specialist Ali Gharavi, MD, associate professor of medicine at CUMC, associate director of the Division of Nephrology, and an internist and nephrologist at NewYork-Presbyterian Hospital.”
“If a physician sees a child with a kidney malformation, that is a warning sign that the child has a genomic disorder that should be looked at immediately because of the risk of neurodevelopmental delay or mental illness later in life,” he said. “This is a major opportunity for personalizing medical care. As we learn which therapies work best for each subgroup, the underlying genetic defect of the patient will dictate what approach to take.”
The current study was the result of a large collaborative effort of CUMC and other medical centers in the US, Italy, Poland, Croatia, Macedonia, and the Czech Republic. It was led by Dr. Gharavi and his colleague Simone Sanna-Cherchi, MD, an associate research scientist in CUMC’s Department of Medicine.
Until now, no studies have linked congenital kidney disease with neurodevelopmental disorders.
“If you talk to clinicians, they tell you that some of these kids behave differently,” Dr. Sanna-Cherchi said. “There has been a general assumption, though, that behavioral or cognitive issues in children with chronic illnesses such as kidney disease stem from the child’s difficulty in coping with the illness. Our study suggests that in some cases, neurodevelopmental issues may be attributable to an underlying genomic disorder, not the kidney disease.”
About 20 percent of kidney defects caused by large DNA mutations
The mutations discovered by Drs. Gharavi and Sanna-Cherchi and their colleagues belong to a class of mutations called copy number variations (CNVs). CNVs are extra copies or deletions of DNA just large enough to contain several genes. When CNVs are present, the “dose” of the affected genes is either lower or higher than normal, potentially leading to a health disorder.
Until the mid-2000s, when effective techniques for detecting CNVs were developed, scientists thought that CNVs caused only a small number of health disorders. Today, tens of thousands of different CNVs have been discovered and linked to several disorders—including autism, schizophrenia, and Parkinson’s disease.
To see if CNVs are involved in congenital kidney defects, Drs. Gharavi and Sanna-Cherchi scanned the genomes of 522 individuals with small and malformed kidneys from medical centers in Europe and United States. About 17 percent of the patients carried a CNV that appeared to contribute to their kidney disorder.
In studies of children with previously discovered CNVs, most of the CNVs had been linked to developmental delays or mental illness. In the current study, about 1 in 10 children had a CNV linked to developmental delays or mental illness.
Though it remains unclear why kidney malformations and neurodevelopment are linked in some cases, it is possible that the same genes involved in kidney development are involved in brain development, Dr. Gharavi said.
Congenital kidney disease may involve hundreds of genes
The search for CNVs in congenital kidney disease also showed that the genes involved in the disease are far more numerous than anticipated.
“We thought we were going to find a few CNVs shared by many patients, but instead we found that virtually every patient with a CNV has a unique one,” Dr. Gharavi said. “Virtually every patient has a unique condition that could not be diagnosed by a standard clinical evaluation.”
Based on their results, Drs. Gharavi and Sanna-Cherchi estimate that there may be hundreds of different genes that can lead to congenital kidney malformation.
The other contributors are Simone Sanna-Cherchi (CUMC), Krzysztof Kiryluk (CUMC), Katelyn E Burgess (CUMC), Monica Bodria (G. Gaslini Institute, Genoa, Italy), Matthew G Sampson (University of Pennsylvania), Dexter Hadley (University of Pennsylvania), Shannon N Nees (CUMC), Miguel Verbitsky (CUMC), Brittany J Perry (CUMC), Roel Sterken (CUMC), Vladimir J Lozanovski (University Children’s Hospital, Skopje, Macedonia), Anna Materna-Kiryluk (Polish Registry of Congenital Malformations, Poznan, Poland), Cristina Barlassina (University of Milan), Akshata Kini (University of Pennsylvania), Valentina Corbani (Sant’ Andrea Hospital, La Spezia, Italy), Alba Carrea (G. Gaslini Institute, Genoa, Italy), Danio Somenzi (University of Parma), Corrado Murtas (G. Gaslini Institute, Genoa, Italy), Nadica Ristoska-Bojkovska (University Children’s Hospital, Skopje, Macedonia), Claudia Izzi (Montichiari Hospital, Italy), Beatrice Bianco (University of Parma), Marcin Zaniew1 (District Children Hospital, Szczecin, Poland), Hana Flogelova (Palacky University, Czech Republic), Patricia L Weng (CUMC), Nilgun Kacak (CUMC), Stefania Giberti (University of Parma), Maddalena Gigante (University of Foggia, Italy), Adela Arapovic (University Hospital of Split, Croatia), Kristina Drnasin (Pediatric Outpatient Clinic, Solin, Croatia), Gianluca Caridi (G. Gaslini Institute, Genoa, Italy), Simona Curioni (University of Milan), Franca Allegri (University of Parma), Anita Ammenti (University of Parma), Stefania Ferretti (Parma University Hospital), Vinicio Goj (Fatebenefratelli Hospital, Milan), Luca Bernardo (Fatebenefratelli Hospital, Milan), Vaidehi Jobanputra (CUMC), Wendy K Chung (CUMC), Richard P Lifton (Yale University), Stephan Sanders (Yale University), Matthew State (Yale University), Lorraine N Clark (CUMC), Marijan Saraga (University of Split, Croatia), Sandosh Padmanabhan (University of Glasgow), Anna F Dominiczak (University of Glasgow), Tatiana Foroud (Indiana University), Loreto Gesualdo (University of Foggia, Italy), Zoran Gucev (University Children’s Hospital, Skopje, Macedonai), Landino Allegri (University of Parma), Anna Latos-Bielenska (Polish Registry of Congenital Malformations, Poznan, Poland), Daniele Cusi (University of Milan), Francesco Scolari (Montichiari Hospital, Italy), Velibor Tasic (University Children’s Hospital, Skopje, Macedonai), Hakon Hakonarson (University of Pennsylvania), and Gian Marco Ghiggeri (G. Gaslini Institute, Genoa, Italy).
The research was supported by the NIH (R01DK080099) and the Italian Telethon Foundation (GGP08050). Researchers received other funding from: the American Heart Association (Scientist Development Grant 0930151N); the American Society of Nephrology (Carl W Gottschalk Research Scholar Grant); NIDDK (K23-DK090207); the Fondazione Malattie Renali nel Bambino; the American Society of Nephrology; the Doris Duke Charitable Foundation; the Polish Ministry of Health; NINDS (NS050487 and NS060113); and the Parkinson’s Disease Foundation.
The authors declare no financial conflicts of interest.
Columbia University Medical Center provides international leadership in basic, pre-clinical, and clinical research; in medical and health sciences education; and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia’s College of Physicians and Surgeons was the first institution in the country to grant the MD degree and is among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest in the United States. For more information, please visit www.cumc.columbia.edu.
NewYork-Presbyterian Hospital, based in New York City, is the nation’s largest not-for-profit, non-sectarian hospital, with 2,409 beds. The Hospital has nearly 2 million inpatient and outpatient visits in a year, including 12,797 deliveries and 195,294 visits to its emergency departments. NewYork-Presbyterian’s 6,144 affiliated physicians and 19,376 staff provide state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine at five major centers: NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian Hospital/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children’s Hospital, NewYork-Presbyterian/The Allen Hospital and NewYork-Presbyterian Hospital/Westchester Division. One of the most comprehensive health care institutions in the world, the Hospital is committed to excellence in patient care, research, education and community service. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area and is consistently ranked among the best academic medical institutions in the nation, according to U.S.News & World Report. The Hospital has academic affiliations with two of the nation’s leading medical colleges: Weill Cornell Medical College and Columbia University College of Physicians and Surgeons. For more information, visit www.nyp.org .
Media Contact: Karin Eskenazi, 212-342-0508, firstname.lastname@example.org